Clinical Trial Update: Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating injections of polyacrylamide hydrogel for HIV-associated lipodystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Lipodystrophy

Drugs mentioned

• Polyacrylamide hydrogel (polyacrylamide hydrogel)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: HIV Infection, Antiretroviral Side Effects | Phase 3 | Status: COMPLETED